Jeffrey Larson Email & Phone Number

SVP R and D @ Tvardi Therapeutics

View Jeffrey's Email & Phone Number

5 free lookup(s).

If you need more lookups, subscriptions start at $34 USD/month.

Jeffrey Larson Location

Houston, TX, US

Jeffrey Larson Work

SVP R and D @ (November 2020 - Present)
Board Member, Houston Methodist, Translational Research Institute @ Houston Methodist (November 2016 - Present)
Vice President Of Product Development @ (June 2018 - November 2020)
Vice President, Nonclinical Development @ Salarius Pharmaceuticals (December 2015 - February 2019)
Vice President, Nonclinical Development @ Beta Cat Pharmaceuticals, now Iterion Therapeutics (December 2015 - June 2018)
Vice President @ Texas BioAlliance (February 2012 - December 2015)
President and CEO @ Parady Consulting, Inc. (January 2008 - January 2012)
VP, Drug Development @ Wildcat Venture Management (October 2010 - December 2011)
Associate VP of Nonclinical Development @ (January 2009 - July 2011)
Senior Director Preclinical Development @ (August 2001 - December 2007)
Director of Toxicology - San Diego @ (December 1999 - July 2001)
Director @ Aronex Pharmaceuticals (January 1999 - January 2000)
Senior Toxicologist @ (January 1997 - May 1998)
Staff Toxicologist @ (August 1993 - January 1997)
Post-doctoral fellow @ Chemical Industry Institute of Toxicology (January 1990 - January 1993)

Jeffrey Larson Education

Washington State University
Ph.D. (Pharmacology/Toxicology)
1986-1990
Minot State University
BA (Environmental Science)
1981-1986

Jeffrey Larson Skills

GLP
Toxicology
CRO
Clinical Development
IND
Biotechnology
Bioterrorism
Drug Development
Medical Devices
Pharmacology
Immunology
Clinical Trials
Pharmaceutical Industry
Biologics
Biochemistry
Oncology
Cell
Protein Chemistry
Pharmacokinetics
FDA
Cell Culture
Drug Discovery
Regulatory Submissions
R&D
Cancer
In Vitro
In Vivo
Lifesciences
Molecular Biology
Monoclonal Antibodies
Microbiology
Therapeutic Areas
Technology Transfer
Biopharmaceuticals
CRO Management
Clinical Pharmacology
U.S. Food and Drug Administration (FDA)
Good Laboratory Practice (GLP)
Life Sciences
Clinical Toxicology
Virology
Mechanisms
Agents
Marketing Strategy
Gap Analysis
Resistance
Licensing
Mouse
Influenza
Administration
Presentation
Strategic Planning
Planning
Investigator Brochures
Annual Budgets
Phase Iii
Filing
Development Strategy
Clinical Data
SAN
Titles
Project Management
Communication
Manuscript
Vivarium
Protocol
Injury
Toxicity
Pathogens
House
Birth
Trials
Supervision
Rpr
Simulations
Design
Risk Assessment
Drinking Water
Litigation
Business Development
Consulting
Gene Therapy
Characterization
Pla
Phase Ii
Drug Delivery
Immunocytochemistry
Components
Government
Training
NDA
Analytical Skill
Bioassay
Manufacturing
Strategic Insights
Developmental
Project Plans
Dogs
Strategy
Efficacy
Grants
Budgets
Treatment
Profit
Deals
Healthcare
Injectable
Kinetics
Budgeting
Commercialization
Cytotoxicity
Drug Safety
Metabolism
Supply
Evaluations
Lists
Supervisor
Inhalation
Resources
Defense
Maa
CTA
Regulatory Requirements
Subcutaneous
Laboratory
Proof
Acute
Facets
Oversight
Proliferation
Clinical Research
HPLC
Regulatory Filings
Assessment
Funding
Modeling

Jeffrey Larson Summary

Jeffrey Larson, based in Houston, TX, US, is currently a SVP R and D at Tvardi Therapeutics. Jeffrey Larson brings experience from previous roles at Houston Methodist, Iterion Therapeutics, Salarius Pharmaceuticals and Beta Cat Pharmaceuticals, now Iterion Therapeutics. Jeffrey Larson holds a 1986 - 1990 Ph.D. in Pharmacology/Toxicology @ Washington State University. With a robust skill set that includes GLP, Toxicology, CRO, Clinical Development, IND and more. Jeffrey Larson has 2 emails and 1 mobile phone numbers on RocketReach.